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MitophagyMutations of the PTEN-induced kinase 1 (PINK1) gene are a cause of autosomal recessive Parkinson's disease (PD).
This gene encodes a mitochondrial serine/threonine kinase, which is partly localized to mitochondria, and has
been shown to play a role in protecting neuronal cells from oxidative stress and cell death, perhaps related to its
role inmitochondrial dynamics andmitophagy. In this study,we report that increasedmitochondrial PINK1 levels
observed in human neuroblastoma SH-SY5Y cells after carbonyl cyanide m-chlorophelyhydrazone (CCCP) treat-
ment were due to de novo protein synthesis, and not just increased stabilization of full length PINK1 (FL-PINK1).
PINK1 mRNA levels were signiﬁcantly increased by 4-fold after 24 h. FL-PINK1 protein levels at this time point
were signiﬁcantly higher than vehicle-treated, or cells treated with CCCP for 3 h, despite mitochondrial content
being decreased by 29%. We have also shown that CCCP dissipated the mitochondrial membrane potential
(Δψm) and induced entry of extracellular calcium through L/N-type calcium channels. The calcium chelating
agent BAPTA-AM impaired the CCCP-induced PINK1mRNA and protein expression. Furthermore, CCCP treatment
activated the transcription factor c-Fos in a calcium-dependent manner. These data indicate that PINK1 expres-
sion is signiﬁcantly increasedupon CCCP-inducedmitophagy in a calcium-dependentmanner. This increase in ex-
pression continues after peak Parkinmitochondrial translocation, suggesting a role for PINK1 inmitophagy that is
downstream of ubiquitination ofmitochondrial substrates. This sensitivity to intracellular calcium levels supports
the hypothesis that PINK1 may also play a role in cellular calcium homeostasis and neuroprotection.
© 2013 The Authors. Published by Elsevier Inc.Open access under CC BY license. Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disor-
der characterized clinically by bradykinesia, rigidity or tremor, and
pathologically by loss of nigrostriatal dopaminergic neurons and the
presence of cytoplasmic protein inclusions known as Lewy bodies. The
etiology of PD is still unknown, but genetic and possibly environmentalión Biomédica en Red sobre
ento de Bioquímica y Biología
ermería y Terapia Ocupacional,
apolo@unex.es
ect.com).
.Open access under CC BY license. factors are thought to be involved (Duvoisin, 1999; Williams et al.,
1999). Mitochondrial dysfunction has consistently been implicated in
the pathogenesis of PD (Langston et al., 1983; Schapira et al., 1989),
and different proteins associated with familial PD, such as PTEN-
induced kinase 1 (PINK1), Parkin, DJ-1, LRRK2 and α-synuclein, have
been reported to localize to mitochondria and affect function (Bonifati
et al., 2003; Devi et al., 2008; Narendra et al., 2008; Papkovskaia et al.,
2012; Silvestri et al., 2005; Valente et al., 2004).
Mutations in the PINK1 gene are responsible for autosomal recessive
familial PD (Valente et al., 2004). PINK1 is a 581 amino acid protein ubiq-
uitously transcribed and encodes a serine/threonine kinase, showing
highhomologywith the Ca2+/calmodulin kinase family. Also, PINK1 con-
tains a N-terminal mitochondrial targeting sequence and a C-terminal
autoregulatory domain (Beilina et al., 2005; Silvestri et al., 2005; Sim
et al., 2006) is predominantly localized to mitochondria, but also is
present in the cytosol (Haque et al., 2008; Valente et al., 2004;
Weihofen et al., 2008; Zhou et al., 2008). Full-length PINK1 (FL-PINK1),
is approximately 63 kDa, and is transcribed in the nucleus, translated
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cleaved by the mitochondrial protease PARL (presenilin-associated
rhomboid-like) at the inner mitochondrial membrane (Deas et al.,
2011; Meissner et al., 2011; Whitworth et al., 2008) to yield two bands
of 55 kDa (ΔN-PINK1) and 45 kDa (ΔN2-PINK1) (Lin and Kang, 2008;
Muqit et al., 2006; Silvestri et al., 2005; Weihofen et al., 2008). The
ΔN-PINK1 species is rapidly degraded by the proteasome (Takatori
et al., 2008).
Previous reports using cell culture models suggest that PINK1 may
play a neuroprotective role under several forms of stress conditions, be-
cause the over-expression ofwild-type PINK1, but notmutant PINK1, pro-
tects against cell death induced by chemical stressors, such as
the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
or the proteasomal inhibitor carbobenzoxyl-leucyl-leucyl-leucinal (MG-
132) (Haque et al., 2008; Petit et al., 2005; Valente et al., 2004). Several
studies inDrosophila, mouse and cell culturemodels, including ﬁbroblasts
from patients with PINK1 mutations (Abramov et al., 2011; Grunewald
et al., 2009; Hoepken et al., 2007; Piccoli et al., 2008), suggest that loss
of PINK1 can be associated with functional and morphological mitochon-
drial effects, oxidative stress and the balance between mitochondrial ﬁs-
sion and fusion (Clark et al., 2006; Gautier et al., 2008; Gegg et al., 2009;
Gispert et al., 2009; Heeman et al., 2011; Park et al., 2006; Poole et al.,
2008; Sandebring et al., 2009; Yang et al., 2008). The mitochondrial dys-
function associated with PINK1 deﬁciency has been linked to perturbed
mitophagy, a cellular process by which old and damaged mitochondria
are engulfed into double membrane vacuoles, called autophagosomes,
that then fuse with lysosomes, resulting in autophagolysosomes, where
mitochondria are subsequently degraded (Kim et al., 2007; Youle and
Narendra, 2011). Loss of Δψm induced by mitochondrial uncouplers,
like carbonyl cyanide m-chlorophelyhydrazone (CCCP), is an initial step
in the removal of this organelle, initiating ﬁssion of the reticular mito-
chondrial network in the damaged mitochondria (Narendra et al., 2008;
Twig et al., 2008). This event inhibits the processing of FL-PINK1 by
PARL, leading to the accumulation of FL-PINK1 on the mitochondrial
outer membrane (Jin et al., 2010; Matsuda et al., 2010; D.P. Narendra
et al., 2010; Vives-Bauza et al., 2010). PINK1 then recruits Parkin to mito-
chondria via phosphorylation (Kondapalli et al., 2012; Matsuda et al.,
2010), whereupon Parkin ubiquitinates mitochondrial proteins such as
VDAC and the mitofusins (Gegg et al., 2010; Geisler et al., 2010; Ziviani
et al., 2010). The ubiquitination of mitochondrial outer membrane pro-
teins such as themitofusins leads to their degradation by the proteasome,
and is required for mitophagy (Chan et al., 2011; Tanaka et al., 2010).
Loss of PINK1 function results in decreased ATP synthesis by mito-
chondria, impaired mitochondrial calcium handling and increased oxida-
tive stress in a time-dependent manner (Gautier et al., 2008; Gegg et al.,
2009). The impairment of mitochondrial function is coincident with de-
creased macroautophagy ﬂux (Gegg et al., 2010). Restoration of
mitophagy in PINK1-deﬁcient cells by exogenous expression of parkin re-
sults in improved mitochondrial function (Gegg et al., 2010), suggesting
that impaired mitophagy may contribute to the mitochondrial
dysfunction observed in PD.
Calcium plays a central role in regulating neurotransmitter release.
Calcium inﬂux is involved in the release of neurotransmitters by synap-
tic vesicles (Neher and Sakaba, 2008), synaptic plasticity (Zucker, 1999)
and gene transcription (Lyons andWest, 2011). Studies have implicated
abnormal calcium homeostasis as a factor in the pathogenesis of PD,
contributing to mitochondrial oxidative stress (Goldberg et al., 2012;
Guzman et al., 2010) and dopaminergic neuronal death (Beal, 1998),
or increasing levels of Ca2+-binding proteins calretinin and calbindin
to confer some protection (Mouatt-Prigent et al., 1994; Yamada et al.,
1990). Calcium regulation involves a range of different transcription
factors, including c-Fos (FBJ murine osteosarcoma viral oncogene
homolog) (Ng et al., 2012; Premkumar et al., 2000; Thompson et al.,
1995; Zhang et al., 2002), CREB (cyclic AMP response element bind-
ing protein) (Soriano et al., 2006) and NF-κB (nuclear factor-κB)
(Camandola et al., 2005; Furukawa and Mattson, 1998).Furthermore, previous reports have shown that CCCP produces cyto-
solic [Ca2+] ([Ca2+]c) elevations in different cell models (Babcock et al.,
1997; Biswas et al., 1999; Eilam et al., 1990; Herrington et al., 1996;
Komori et al., 2010; Lim et al., 2006; Pereira et al., 2008; Yan et al.,
2012). This is consistent with the calcium entry from the outside
(Ardon et al., 2009) and the inhibition of calcium uptake via the mito-
chondrial uniporter (mCU), pathway driven by the Δψm.
Several studies indicate that PINK1 participates inmitochondrial calci-
um homeostasis (Gandhi et al., 2009; Heeman et al., 2011), possibly reg-
ulating the mitochondrial permeability transition pore (mPTP) (Akundi
et al., 2011; Gautier et al., 2012), mitochondrial Na+/Ca2+ exchanger
(NCXmito) (Gandhi et al., 2009) ormCU (Marongiu et al., 2009). Isoforms
NCX2andNCX3mayact downstreamof PINK1, preventingmitochondrial
calcium overload (Wood-Kaczmar et al., 2013).
In the current study, we show that the increase in FL-PINK1 levels
seen upon CCCP treatment is not solely due to the stabilization of the
protein on the mitochondrial outer membrane and decreased degrada-
tion by the proteasome (Jin et al., 2010; Matsuda et al., 2010; Narendra
et al., 2008), but also to de novo PINK1 synthesis in a calcium-
dependent pathway. Moreover, CCCP induced c-Fos activation through
the extracellular calcium entrance by the L-type and N-type voltage-
dependent calcium channels (VDCCs).Material and methods
Cell culture
The human SH-SY5Yneuroblastoma cell linewas cultured in 1:1 (v/v)
DMEM:F12 (Ham) media containing 0.9 g/l glucose and supple-
mented with 10% fetal bovine serum, 1 mM sodium pyruvate, non-
essential amino acids, and penicillin–streptomycin. The cells were
seeded at a density of 2 × 106 in a 75-cm2 tissue culture ﬂask
(Corning, New York, NY) and incubated at 37°C under saturating hu-
midity in 5% CO2/95% air.Treatments
Cells were plated at a density of 1 × 106 cells/ml, and treated with
CCCP (10 μM, Sigma-Aldrich, St. Louis, MO) or an equivalent volume
of ethanol (vehicle control, Sigma-Aldrich, St. Louis, MO) (Gegg et al.,
2010). For the inhibition of transcription and translation, actinomycin
D (Act. D) (5 μg/ml, Fisher Scientiﬁc, Waltham, MA) and cycloheximide
(CHX) (100 μg/ml, Sigma-Aldrich, St. Louis, MO) were employed, re-
spectively. The ubiquitin-proteasome system (UPS) and autophagy
were inhibited with MG-132 (5 μM, Tocris Bioscience, Bristol, UK), and
baﬁlomycin A1 (Baf. A1) (100 nM, Sigma-Aldrich, St. Louis,MO), respec-
tively. BAPTA-AM (5 μM, Molecular Probes, Life Technologies, Carlsbad,
CA) and EGTA (500 μM, Sigma-Aldrich, St. Louis, MO) were used to che-
late intracellular calcium and extracellular calcium, respectively. To inhib-
it the chaperone Hsp90, cells were incubated with 17-AAG (1 μM,
Calbiochem, Merck KGaA, Darmstadt, Germany). Cells were treated
with all the inhibitors 1 h prior to CCCP, except 17-AAG, which was
added 3 h before recovering the cells because of its toxicity. For the
calcium live-cell imaging, we stimulated SH-SY5Y cells with these
compounds just before the measurement: thapsigargin (1 μM, Sigma-
Aldrich, St. Louis, MO), rotenone (10 μM, Sigma-Aldrich, St. Louis, MO)
and Baf. A1 (100 nM) to deplete calcium stores (endoplasmic reticulum
(ER), mitochondria and lysosomes, respectively); nifedipine (10 μM,
Sigma-Aldrich, St. Louis, MO) and ω-conotoxin GVIA (ω-CTX) (2 μM,
Alomone Labs, Jerusalem, Israel), L- and N-type VDCC blockers, respec-
tively. In addition, cells were incubated with the following treatments
for 24 h: calcium ionophore ionomycin (0.1–2 μM, Sigma-Aldrich,
St. Louis, MO) and L-type VDCC agonist Bay K 8644 (0.25–5 μM, Tocris
Bioscience, Bristol, UK).
Fig. 1.Mitochondrial damage and autophagy induction in SH-SY5Y CCCP-treated cells. (A) SH-SY5Y cellswere exposedwith 10 μMCCCP,with vehicle (0.05% (v/v) ethanol) orwithout any
treatment (control), lysed and CS activitymeasured. Data are expressed as nmol/min/mg protein (#p N 0.05; ***p ≤ 0.001). (B and C) SH-SY5Y cells were treatedwith 10 μMCCCP for 0, 3
or 24 h and lysates separated by SDS-PAGE and Western-blotting performed. Blots were probed with antibodies against two inner mitochondrial membrane proteins, COX IV and
prohibitin 1. β-actin was used as a loading control. (B) Representative blot of at least three independent experiments. (C) Densitometry of each band expressed as % of control
(#p N 0.05; *p ≤ 0.05; **p ≤ 0.01). (D and E) SH-SY5Y cells were exposed with 10 μMCCCP, with vehicle (0.05% (v/v) ethanol) or without any treatment (control) for 24 h, and stained
with TMRM to assess Δψm by immunoﬂuorescence. (D) Representative microphotographs of TMRM stain. Scale bar represents 10 μm. The arrows highlight cells with low Δψm. (E)
TMRM ﬂuorescence intensity per cell (in AU) by immunoﬂuorescence (# p N 0.05; *** p ≤ 0.001). (F and G) SH-SY5Y cells were exposedwith 10 μMCCCP, with vehicle (0.05% (v/v) eth-
anol) or without any treatment (control), harvested by trypsinization at different times and lysed. The ratio LC3-II/LC3-I was determined byWestern-blotting.α-tubulin expression was
used as a loading control. (F) Representative blot of at least three independent experiments. (G) Densitometry of each band expressed in arbitrary units of intensity (***p ≤ 0.001). Mo-
lecularmass is indicated in kilodaltons (kDa) next to the blots. Datawere expressed asmean ± SEM;n = 3. (H and I) SH-SY5Y cellswere transfectedwithmCherry-GFP-LC3B plasmid for
24 h and treatedwith 10 μMCCCP for 0, 3 or 24 h and ﬁxed. (H) Representative immunoﬂuorescencemicrophotographs. Autophagolysosomes and autophagosomeswere labeled by red
(mCherry-LC3B) and yellow puncta (mCherry-GFP-LC3B), respectively. The boxes highlight the pattern of each condition. (I) Percentages of mCherry (+) puncta per cell (#p N 0.05;
***p ≤ 0.001). Scale bar represents 10 μm.
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Following treatments, cells were washed with PBS and lysed in 0.25%
(v/v) Triton X-100 (Sigma-Aldrich, St. Louis, MO) in PBS supplemented
with protease and phosphatase inhibitors. Debris was removed by centri-
fugation and citrate synthase (CS) activitywasmeasured by following the
oxidation of 5,5′-Dithiobis(2-nitrobenzoic acid) (Sigma-Aldrich, St. Louis,
MO) in a spectrophotometer (absorbance at 412 nm) over time at 30°C in
thepresence of acetyl co-enzymeA(Sigma-Aldrich, St. Louis,MO) andox-
aloacetate (Sigma-Aldrich, St. Louis, MO) (Clark and Land, 1974). Protein
concentration was measured based on the bicinchoninic acid (BCA)
method, using a Bicinchoninic Acid Kit (Sigma-Aldrich, St. Louis, MO)
using bovine serum albumin (BSA) as a standard. The enzyme activity
was expressed as nmol/min/mg protein.
Plasmid transfection
For the over-expression of PINK1 (to compare with the endogenous
protein), SH-SY5Y cells were transfected with pCMV6-Neo vector con-
taining full-length wild-type PINK1 cDNA (Origene), as previously
described (Gegg et al., 2009), using FuGENE® 6 Transfection Reagent
(Roche, Indianapolis, IN), according to the manufacturer's protocol.
mCherry-Parkin (Addgene plasmid 23956) (Narendra et al., 2008), GFP-
LC3 (Kabeya et al., 2000) (Dr. Tamotsu Yoshimori gift) and
mCherry-GFP-LC3B (Pankiv et al., 2007) (Dr. Terje Johansen gift)constructs were transfected as previously reported (Bravo-San Pedro
et al., 2013).
Transient transfection with PINK1/c-fos siRNA
Cells (1.8 × 105 cells/ml) were transfected with a pair of PINK1
siRNAs (5 nM each), c-fos siRNA (50 nM) or 10 nM scrambled control
siRNA (Ambion negative control siRNA #1, Enzo Life Sciences, New
York, NY) using HiPerfect transfection reagent (Qiagen, Crawley, UK)
(for PINK1 siRNA) or Lipofectamine™ 2000 transfection reagent (Invitro-
gen, Life Technologies, Carlsbad, CA) (for c-fos siRNA). A combination
of PINK1 siRNA pair was used (SI00287931, sense strand: GACGCUGUU
CCUCGUUAUGAA; and SI00287924, sense strand: CGGACGCUGUUCC
UCGUUAU) (Qiagen, Crawley, UK). The c-fos siRNA (SI02781429) had
the following sense strand: CCAAUAUUAUACUAAGAAATT (Qiagen,
Crawley, UK).
Quantitative PCR
Total RNA was extracted from SH-SY5Y cells using the RNeasy Mini
Kit (Qiagen, Crawley, UK). cDNA was synthesized by the QuantiTect
Reverse Transcription Kit (Qiagen, Crawley, UK), adding 500 ng of
template RNA. PINK1 gene expression was measured by quantitative
real-time PCR (qPCR) with SYBR Green reagents (Applied Biosystems,
Life Technologies, Carlsbad, CA). To normalize the results, housekeeping
Fig. 2. Cytotoxic effect of CCCP. (A) SH-SY5Y cells were exposed with 10 μM CCCP, with
vehicle (0.05% (v/v) ethanol) or without any treatment (control) for 24 h, and labeled
with Ho to measure the chromatin condensation. Graphic shows percentages of cells
with chromatin condensation (#p N 0.05; **p ≤ 0.01). The arrows highlight nuclei with
chromatin condensation. (B) SH-SY5Y cells were exposed with 10 μM CCCP, with vehicle
(0.05% (v/v) ethanol) or without any treatment (control) for 24 h, harvested by
trypsinization and labeledwith PI tomeasure cell viability by ﬂow cytometry. Percentages
of PI-positive cells (#p N 0.05; **p ≤ 0.01) and representative single-parameter histo-
gram of PI measurement. Data were expressed as mean ± SEM; events = 10,000.
Fig. 3. CCCP effect on PINK1 protein levels over time. (A and B) SH-SY5Y cells were ex-
posed with 10 μM CCCP, with vehicle (0.05% (v/v) ethanol) or without any treatment
(control), harvested by trypsinization at different times and lysed. The protein levels of
PINK1were determined byWestern-blotting. α-tubulin expression was used as a loading
control. (A) Representative blot of at least three independent experiments. (B) Densitom-
etry of each band expressed in arbitrary units of intensity (***p ≤ 0.001). (C and D) SH-
SY5Y cells were transfected with PINK1 siRNA or scrambled control siRNA for 3 days
and treated with 10 μM CCCP, with vehicle (0.05% (v/v) ethanol) or without any treat-
ment (control), harvested by trypsinization at 24 h of treatment. The protein levels of
PINK1were determined byWestern-blotting.α-tubulin expressionwas used as a loading
control. (C) Representative blot of at least three independent experiments. (D) Densitom-
etry of each band expressed in arbitrary units of intensity (#p N 0.05; ***p ≤ 0.001).
Molecular mass is indicated in kDa next to the blots. Data were expressed as mean ±
SEM; n = 3.
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was used. Analysis of relative gene expression was calculated using
the comparative threshold (2−ΔΔCt) method (Pfafﬂ, 2001). Primer
sequences were performed as previously described (Gegg et al., 2009).
Western-blotting
Proteinwas obtained using a lysis buffer composedof 1% (v/v) Triton
X-100 in PBS supplemented with protease and phosphatase inhibitors,
and quantiﬁed according to the CS activity protocol above. Equal
amounts of protein (50–75 μg/condition) were resolved by 4–20%
SDS-gel electrophoresis and transferred to polyvinylidene ﬂuoride
(PVDF) membranes (Hybond P, GE Healthcare, Chalfont St. Giles, UK)
according to a partially modiﬁed conventional method (Fuentes et al.,
2000). Immunodetection included transferring and blocking the mem-
brane with TBST (Tris-buffered salinewith Tween 20) buffer containing
10% non-fat dried milk. Blots were probed with antibodies against
PINK1 (clone BC100-494, Novus Biologicals, Southpark Way, Littleton,
CO), subunit IV of cytochrome c oxidase (COX IV, ab14744, abcam),
prohibitin 1 (#2426, Cell Signaling Technology, Beverly, MA), LC3B
(#2775, Cell Signaling Technology, Beverly, MA), p-c-Fos (Ser32)
(#5348, Cell Signaling Technology, Beverly, MA), c-Fos (#2250, Cell Sig-
naling Technology, Beverly, MA), β-actin (ab8227, Abcam, Cambridge,
UK), α-tubulin (clone TU-02, Santa Cruz Biotechnology, Santa Cruz,
CA), Tom20 (clone F-10, Santa Cruz Biotechnology, Santa Cruz, CA),
and Lamin A/C (612162, BD Biosciences, Franklin Lakes, NJ). Blots
were visualized with respective peroxidase-conjugated secondary anti-
bodies (Bio-Rad, Hercules, CA) and visualized by chemiluminescenceusing ECL substrate (Pierce, Thermo Fisher Scientiﬁc, Rockford, IL). The
β-actin and α-tubulin content was established as loading control,
Tom20 as mitochondrial loading control and Lamin A/C as nuclear
loading control. The density of bands was determinated using ImageJ
software (NIH, Bethesda, MD). For quantitative studies, three separate
western blots were analyzed.
Mitochondrial isolation
Cell pellets (1 × 107 cells/condition)were washedwith PBS supple-
mented with protease and phosphatase inhibitors and homogenized
with a glass-teﬂon homogenizer in isolationmedium (250 mM sucrose,
1 mM EDTA, 10 mM Tris, pH 7.4, supplemented with protease and
phosphatase inhibitors). Nuclei were removed by centrifugation at
Fig. 4.Mitochondrial localization of PINK1 in CCCP-treated SH-SY5Y cells. (A–C) SH-SY5Y
cells were exposed 24 h with 10 μM CCCP, with vehicle (0.05% (v/v) ethanol) or without
any treatment (control), ﬁxed and immunostained for PINK1 (green) and Tom20 (red).
(A) Representative immunoﬂuorescence microphotographs. The boxes highlight high in-
tensity of PINK1 and fragmented mitochondria, respectively. (B) Fluorescence intensity
per cell (in AU), stainingwith anti-PINK1 antibody (#p N 0.05; ***p ≤ 0.001). (C) Percent-
ages of cellswith fragmentedmitochondria, labeledwith anti-Tom20 antibody (#p N 0.05;
***p ≤ 0.001). Scale bar represents 10 μm. Data were expressed as mean ± SEM;
n = 200. (D andE) SH-SY5Y cellswere immunostained after the treatment and performed
with confocal techniques. (D) Representative confocal microphotographs, showing
the localization of PINK1 (green) on mitochondria (Tom20; red). (E) Confocal analysis of
the mitochondrial localization of PINK1, using Mander's colocalization coefﬁcient
(***p ≤ 0.001). Scale bar represents 10 μm.
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pernatant) andmitochondrial fractions, and the pelletwas resuspended
in isolation medium. Protein concentration was measured using the
BCA method, as described in the CS assay.
Flow cytometry
After exposure to different experimental conditions, SH-SY5Y cells
were trypsinized and labeled with different ﬂuorochromes. Tomeasure
the intracellular calcium levels, cells were incubated with Fluo-3 AM
(1 μM, Molecular Probes, Life Technologies, Carlsbad, CA) for 30 min
at 37 °C. Δψm was assessed with tetramethylrhodamine methyl ester
perchlorate (TMRM) (25 nM, Molecular Probes, Life Technologies,
Carlsbad, CA) for 30 min at 37°C. Propidium iodide (PI) (1 μg/ml,
Sigma-Aldrich, St. Louis, MO) was used to determine the cell viability
(Gonzalez-Polo et al., 2007). PI-negative cells were considered to be vi-
able. Single-parametric analysis was performed with a Cytomics FC500
MPL Flow Cytometer (Beckman Coulter, Miami, FL), which has an argon
ion laser operating at 488 nm, with subsequent data analysis using
Summit v4.2 software (DakoCytomation, Fort Collins, CO). All measure-
mentswere developed in duplicate (10,000 cells/sample) and in at least
three independent experiments.Immunoﬂuorescence
Tomeasure Δψmby this technique, cells were washedwith PBS and
incubated with TMRM for 30 min at 37°C. For the detection of endoge-
nous PINK1 and mitochondrial network, cells were seeded on cover-
slips, ﬁxed with paraformaldehyde (4% w:v), permeabilized with
Triton X-100 solution (Triton X-100 0.2% in PBS) and stained with
PINK1 (clone BC100-494, Novus Biologicals, Southpark Way, Littleton,
CO) and Tom20 (clone F-10, Santa Cruz Biotechnology, Santa Cruz,
CA), then cells were incubated with the respective Alexa Fluor 488
anti-rabbit, 488 anti-mouse and 568 anti-mouse secondary antibodies
(Molecular Probes, Life Technologies, Carlsbad, CA).Mitochondrialmor-
phology was determined using ImageJ software. Mitochondria were
scored for their circularity, with 0 being a straight line, and 1.0 a perfect
circle. In this sense, mitochondria were designated fragmented when
the circularity was between 0.60 and 1.00 and tubular when between
0.00 and 0.60. For the transcription factor staining, cells were prepared
in the same way, using p-c-Fos (Ser32) (#5348, Cell Signaling Technol-
ogy, Beverly, MA) and c-Fos (#2250, Cell Signaling Technology, Beverly,
MA). The nuclear morphology and chromatin condensation were la-
beled with Hoechst 33342 (Ho) (2 μM; Sigma-Aldrich, St. Louis, MO).
Cells with condensed nuclei were considered not to be viable. TMRM
and Ho staining were analyzed using an inverted ﬂuorescence micro-
scope (IX51, Olympus, Tokyo, Japan) equipped with a camera (DP70,
Olympus, Tokyo, Japan). The colocalization of PINK1 with mitochon-
dria and nuclear c-Fos, images were taken with a confocal scanning
laser (Nikon A1, Tokyo, Japan) coupled to an inverted microscope
(Eclipse Ti, Nikon, Tokyo, Japan). The quantitative measurement of
the ﬂuorescence signal was performed using ImageJ software. For
the colocalization studies, the samples were quantiﬁed using the
JaCoP plug-in for ImageJ, based in Mander's coefﬁcient (Bolte and
Cordelieres, 2006), analyzing at least 30 cells for each condition. For
the other measurements, we counted at least 200 cells per condition.
In the nuclear colocalization experiments, pictures were converted
into “6_shades” LUT, setting in ImageJ software.
Measurement of intracellular calcium
To perform calciummeasurements, cells were seeded at a density of
1 × 106 cells/ml on coverslips of 14 mm. Cells were loaded with Fura-
2 AM (5 μM, Molecular Probes, Life Technologies, Carlsbad, CA) for
45 min at 37°C in Locke's K25 buffer that contained 137 mM NaCl,
5 mM KCl, 4 mM NaHCO3, 2 mM CaCl2, 1 mM MgCl2, 5 mM glucose,
and 10 mM HEPES, pH 7.4, and then washed three times with Locke's
K25 buffer at 37 °C to remove extracellular Fura-2 AM. Fura-2was excit-
ed alternatively at 340 nmand380 nm, and emitted at 510 nmusing an
illumination system (MT20, Olympus, Tokyo, Japan). The ratio of ﬂuo-
rescent signals obtained at 340 nm and 380 nm excitation wavelengths
was recorded at 2 second intervals during 10–15 min, depending on
the experiment. F340/F380 ratio was used to represent the [Ca2+]i in
the cells. The ﬂuorescence of Fura-2-loaded SH-SY5Y cells was moni-
tored and acquired with a CCD camera (Hammamatsu Orca-ER,
Shizouka, Japan) for ratiometric imaging, mounted on an inverted mi-
croscope (IX81, Olympus, Tokyo, Japan). Images were analyzed using
the software Cell^R (Olympus, Tokyo, Japan). Fields of cells and regions
of interest (ROIs) were chosen based on homogenous and equal cell
densities. For the calcium channel blockers (nifedipine and ω-CTX),
cells were treated before theyweremeasured as was described in treat-
ments. All the experiments were performed at 37°C.
Nuclear isolation
Nuclear and cytoplasmic fractions were obtained from cell lysates
(1 × 107 cells/condition), using the EpiQuik™ Nuclear Extration Kit
(Epigentek, Farmingdale, NY). Protein concentration was determined
by the BCA method assay, how it is detailed in the CS measurement.
Fig. 5.CCCP-inducedmitophagy is parallel tomitochondrial PINK1 localization. (A andB) SH-SY5Y cells were exposedwith 10 μMCCCPorwith vehicle (0.05% (v/v) ethanol), harvested by
trypsinization at different times, mitochondria isolated andWestern-blotting performed. Blots were probedwith antibodies against PINK1 and LC3B.α-tubulin and Tom20were used as a
cytosolic andmitochondrial loading control, respectively. (A) Representative blot of at least three independent experiments. (B) Densitometry of each band expressed in arbitrary units of
intensity (***p ≤ 0.001).Molecularmass is indicated in kDanext to the blots. (C–F) SH-SY5Y cellswere transfectedwithmCherry-Parkin orGFP-LC3 and exposed 6, 12 or 24 hwith 10 μM
CCCP or with vehicle (0.05% (v/v) ethanol), ﬁxed and immunostained for Tom20 (green/red). (C and D) Representative immunoﬂuorescence microphotographs of 6 hour treated-cells.
The boxes highlight mitochondrial localization ofmCherry-Parkin and GFP-LC3, respectively. (E) Percentages of cells with mCherry-Parkin onmitochondria, labeled with anti-Tom20 an-
tibody (***p ≤ 0.001). (F) Percentages of cells with GFP-LC3 on mitochondria, labeled with anti-Tom20 antibody (***p ≤ 0.001). Scale bar represents 10 μm.
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Each experimentwas repeated at least three times,with a satisfacto-
ry correlation between the results of individual experiments. The data
shown are those of a representative experiment; each groupwas the av-
erage of three to four culture dishes. In each experiment, the differences
between groups were assessed by appropriate statistical methods. Spe-
ciﬁcally, statistical signiﬁcance was evaluated with two-tailed unpaired
Student's t-test and ANOVA test, and all comparisons with p value less
than 0.05 (p b 0.05) were considered statistically signiﬁcant. The data
are expressed as the mean ± SEM. All data were analyzed with SPSS
Statistics 20 (IBM, Chicago, IL) for Windows.
Results
Mitochondrial damage and autophagy induction by CCCP
CCCP is a lipid-soluble weak acid, which acts as a very powerful
mitochondrial uncoupling agent that carries protons across the mito-
chondrial inner membrane, thereby diminishing the proton gradient.
To investigate the molecular events in CCCP-induced depolarization,
according to previous reports (D. Narendra et al., 2010; D.P. Narendra
et al., 2010; Vives-Bauza et al., 2010), cells were treated with 10 μM
CCCP. Themitochondrial content in SH-SY5Y cells was assessed bymea-
suring the CS activity (Gegg et al., 2010; Wood-Kaczmar et al., 2008).
CCCP treatment produced a signiﬁcant decrease in mitochondrial mass
(29.2 ± 3.1%) (mean ± standard deviation [SD]) after 24 h (Fig. 1A),
meanwhile a short exposure (3 h) did not result in decreased mito-
chondrial content. Furthermore, washing away of CCCP after 6 h oftreatment, and measuring mitochondrial content 18 h later (24 h
after start of treatment), no longer resulted in a signiﬁcant decrease in
mitochondrial content (data not shown). The decrease in CS activity
was not due to a failure of the enzyme being imported in to mitochon-
dria because of a lack of mitochondrial membrane potential, as we have
previously shown that (a) knockdown of PINK1 or parkin reverses the
decrease in CS activity following CCCP treatment and (b) CS loss was
greater in SH-SY5Y over expressing parkin, when compared to SH-
SY5Y cells with endogenous Parkin levels (Gegg et al., 2010).
To further prove that the decrease of CS activity after 24 h of CCCP
treatment was due to the loss of mitochondria, we analyzed mitochon-
drial protein levels byWestern-blotting, checking two inner mitochon-
drial membrane proteins, COX IV and prohibitin 1. CCCP treatment for
24 h caused a 61% reduction in prohibitin 1 and a 22% reduction in
COX IV (Figs. 1B and C), reﬂecting the fall in mitochondrial content. To
prove that CCCP produced Δψm reduction, we measured TMRM in
SH-SY5Y by immunoﬂuorescence. In this sense, CCCP-treated cells
shown a Δψm dissipation at 24 h (10.5 ± 5.1 arbitrary units (AU) of
TMRM ﬂuorescence intensity/cell), when compared with untreated cells
(37.6 ± 5.1 AU) or vehicle-treated cells (35.6 ± 8.1 AU) (Figs. 1D
and E). This Δψm decrease was observed after 1 hour CCCP exposure
(data not shown), and we conﬁrmed this result by ﬂow cytometry
(data not shown).
To conﬁrm that CCCP is inducing autophagy in our cell model, and
thereby the mechanism by which mitochondria are being degraded,
we analyzed the autophagic protein LC3. LC3 presents as a cytosolic
form (called LC3-I), which can then be conjugated to phosphatidyletha-
nolamine to generate LC3-phosphatidylethanolamine conjugate (LC3-
II), that is then recruited to autophagosomes. An increase in LC3-II
Fig. 6. Increase of PINK1 gene expression, and not its stabilizationwith chaperones, after the CCCP exposure. (A) SH-SY5Y cells were exposedwith 10 μMCCCP orwith vehicle (0.05% (v/v)
ethanol) at different times, and PINK1 mRNA levels measured by reverse transcription and quantitative PCR. Relative expression was determined using GAPDH as housekeeping gene
(#p N 0.05; **p ≤ 0.01; ***p ≤ 0.001). (B and C) SH-SY5Y cells were preincubated 1 h with 5 μg/ml Act. D, 100 μg/ml CHX or vehicle (0.1% (v/v) DMSO), exposed with 10 μM CCCP,
with vehicle (0.05% (v/v) ethanol) or without any treatment (control) for 24 h, harvested by trypsinization and lysed. The protein levels of PINK1 were determined by Western-
blotting. α-tubulin expression was used as a loading control. (B) Representative blot of at least three independent experiments. (C) Densitometry of each band expressed in arbitrary
units of intensity (#p N 0.05; ***p ≤ 0.001). (D–F) SH-SY5Y cells were preincubated 1 h with 5 μMMG-132 or 100 nM Baf. A1, exposed with 10 μM CCCP, with vehicle (0.05% (v/v) eth-
anol) or without any treatment (control) for 24 h, incubated with 1 μM 17-AAG 3 h before collecting cells, harvested by trypsinization and lysed. The protein levels of PINK1 and COX IV
were determined byWestern-blotting. α-tubulin expression was used as a loading control. (D) Representative blot of at least three independent experiments. (E) Densitometry of each
band expressed in arbitrary units of intensity (#p N 0.05; ***p ≤ 0.001). (F) Densitometry of each band expressed in arbitrary units of intensity (#p N 0.05; ***p ≤ 0.001). Molecularmass
is indicated in kDa next to the blots. Data were expressed as mean ± SEM; n = 3.
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this sense, we observed that the ratio between both isoforms (LC3-II/
LC3-I) increased in CCCP-treated cells in a time-dependent manner,
peaking at 12 h treatment (Figs. 1F and G). To afﬁrm that autophagic
ﬂux is active, we measured LC3 turnover by lysosomes, using the
mCherry-GFP-LC3B plasmid (GFP ﬂuorescence is quenched by the
lower pH levels in autophagolysosomes, whereasmCherry ﬂuorescence
is not). The presence of the uncoupler increased the number of red
puncta (mCherry-LC3B) and, therefore, the autophagolysosomes over
time (21.0 ± 3.1% and 80.3 ± 10.0% at 3 and 24 h of CCCP treatment,
respectively), whereas GFP did not accumulate (Figs. 1H and I). This
conﬁrms that the increase in LC3-II protein levels seen after CCCP treat-
ment (Figs. 1F and G) was due to increased autophagy ﬂux.
Cytotoxic effect of CCCP
To evaluate if thismitochondrial uncoupler could induce cell death,
we measured typical patterns such as chromatin condensation
and nuclear membrane permeabilization. Nuclei of untreated and
vehicle-treated cells had no morphologic changes, while CCCP expo-
sure increased the number of nuclei with chromatin condensation(24.9 ± 3.0%) (Fig. 2A) and positive PI staining (19.3 ± 4.5%) 24 h
after treatment (Fig. 2B).CCCP effect on PINK1 protein levels
To further investigate the role of PINK1 in the mitochondrial dam-
age, we determined the levels of PINK1 protein after CCCP exposure,
demonstrating how the presence of the uncoupler produced a gradual
and signiﬁcant accumulation of endogenous FL-PINK1 protein in a
time-dependent manner (Figs. 3A and B). Noticeably, the signiﬁcant
increase in FL-PINK1 after 24 h of CCCP treatment occurred at a
time when mitochondrial content was decreased (Figs. 1A–C). Pro-
teolytically processed forms of PINK1 (ΔN-PINK1) were undetectable
in CCCP-treated cells. FL-PINK1 was not observed in untreated or
vehicle-treated cells. However, FL-PINK1 levels fell within 15 min of
CCCPwashout, suggesting that its presence depends on themitochon-
drial depolarization (data not shown). To conﬁrm that the band de-
tected was FL-PINK1, we silenced PINK1 expression (Figs. 3C and D)
or over-expressed full-length wild-type PINK1 without a tag (data
not shown).
Fig. 7. Involvement of extracellular calcium in PINK1 levels. (A–D) Time courses of Ratio (F340/F380) in Fura-2 AM loaded SH-SY5Y cells to determine cytosolic calcium changes. (A) Time
course of [Ca2+]cyt changes in SH-SY5Y cells after the addition of 10 μMCCCP in Ca2+-free Locke's K25 buffer. (B) Time course of [Ca2+]cyt changes in SH-SY5Y cells induced by 10 μMCCCP
in complete Locke's K25 buffer (***p ≤ 0.001 between +Ca2+-CCCP-treated (n = 22) and−Ca2+-CCCP-treated cells (n = 12)). (C) Time course of [Ca2+]cyt changes in SH-SY5Y cells
after the treatment of 10 μM nifedipine and 10 μM CCCP in complete Locke's K25 buffer (*p ≤ 0.05 between +Ca2+-nifedipine-CCCP-treated (n = 10) and +Ca2+-CCCP-treated cells).
(D) Time course of [Ca2+]cyt changes in SH-SY5Y cells in the presence of 2 μM ω-CTX and 10 μM CCCP in complete Locke's K25 buffer (**p ≤ 0.01 between+Ca2+-ω-CTX-CCCP-treated
(n = 31) and+Ca2+-CCCP-treated cells). (E and F) SH-SY5Y cells were preincubated 1 hwith 5 μMBAPTA-AM, exposedwith 10 μMCCCP orwith vehicle (0.05% (v/v) ethanol), harvest-
ed by trypsinization at different times and lysed. The protein levels of PINK1were determined byWestern-blotting.α-tubulin expressionwas used as a loading control. (E) Representative
blot of at least three independent experiments. (F) Densitometry of each band expressed in arbitrary units of intensity (#p N 0.05; *p ≤ 0.05; ***p ≤ 0.001). (G and H) SH-SY5Y cells were
preincubated 1 h with 5 μM BAPTA-AM, exposed 6 or 24 h with 10 μM CCCP or with vehicle (0.05% (v/v) ethanol), mitochondrial isolated and Western-blotting performed. Tom20 was
used as a mitochondrial loading control. (G) Representative blot of at least three independent experiments. (H) Densitometry of each band expressed in arbitrary units of intensity
(**p ≤ 0.01; ***p ≤ 0.001). Molecular mass is indicated in kDa next to the blots. Data were expressed as mean ± SEM; n = 3.
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We next examined the subcellular localization of PINK1, analyzing
by immunoﬂuorescence endogenous PINK1 and co-staining mitochon-
dria with Tom20, an outer mitochondrial membrane protein. In control
and vehicle-treated cells for 24 h, endogenous PINK1 levels were low
(1.2 ± 0.4 AU of PINK1 ﬂuorescence intensity/cell in control and
1.8 ± 0.3 in vehicle-treated cells) andmitochondria showed the typical
tubular structure (3.2 ± 2.9% of cells with fragmented mitochondria in
control and 5.9 ± 4.3% in vehicle-treated cells). Meanwhile, in CCCP-
treated cells, levels of PINK1 increased (4.4 ± 1.0 AU of ﬂuorescence
intensity/cell) (Figs. 4A and B) and the mitochondrial network was
fragmented (92.1 ± 4.8%) (Figs. 4A and C), showing how there is an
accumulation of PINK1 in these cells co-localized with damaged mito-
chondria (Figs. 4D and E) (0.54 ± 0.09 Mander's colocalization coefﬁ-
cient in CCCP-treated cells compared to 0.15 ± 0.05 in vehicle-treated
cells).
Furthermore, we observed that PINK1 levels increased in the
mitochondria-rich fraction in a time-dependent manner after CCCP
treatment, whereas in the cytosolic-rich fraction no bandwas observed(Figs. 5A and B). We also noted that there was an increase in LC3-II
levels in the mitochondria rich fraction following CCCP treatment,
being higher at 12 h (Figs. 5A and B). We conﬁrmed this mitochondrial
localization of LC3 by immunoﬂuorescence, using GFP-LC3 plasmid
(Figs. 5D and F). Aswith previous reports, accumulation of Parkin onmi-
tochondria following CCCP treatment occurred. However, while PINK1
continued to accumulate on damaged mitochondria after 24 h, the
amount of Parkin did not follow the same pattern (Figs. 5C and E),
decreasing at this time, as LC3 protein (Figs. 5A, B, D and F).
Increased PINK1 gene expression after the CCCP exposure
We assessed whether the increase of endogenous PINK1 in mito-
chondria after CCCP treatment was due to an increase in gene expres-
sion level or a possible chaperone-mediated stabilization. For this
purpose, wemeasured themRNA levels of PINK1 by qPCR. In a short pe-
riod of time (3 h), there were no differences, but we observed a signif-
icant increase of the PINK1 mRNA in a time-dependent manner, and
was signiﬁcantly higher at 6 (1.76 ± 0.22 times more than vehicle-
treated cells at 3 h) and 24 h after CCCP treatment (4.01 ± 0.66 times
Fig. 8. PINK1 calcium-dependent gene expression. (A and B) SH-SY5Y cells were preincu-
bated 1 h with 5 μM BAPTA-AM or 500 μM EGTA, exposed 6 or 24 h with 10 μM CCCP or
with vehicle (0.05% (v/v) ethanol), and PINK1 mRNA levels measured by reverse tran-
scription and quantitative PCR. Relative expression was determined using GAPDH as
housekeeping gene antibody. (A) Relative PINK1mRNA expression after 6 hour CCCP ex-
posure and calcium chelation (***p ≤ 0.001). (B) Relative PINK1 mRNA expression after
24 hours of CCCP treatment and calcium chelation (#p N 0.05). (C and D) SH-SY5Y cells
were preincubated 1 h with 5 μM BAPTA-AM or 500 μM EGTA, exposed 24 h with
10 μM CCCP, harvested by trypsinization and lysed. The protein levels of PINK1 were
determined by Western-blotting. α-tubulin expression was used as a loading control.
(C) Representative blot of at least three independent experiments. (D) Densitometry of
each band expressed in arbitrary units of intensity (*p ≤ 0.05; ***p ≤ 0.001). Molecular
mass is indicated in kDa next to the blots. Data were expressed as mean ± SEM;
n = 3.
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sistent when we studied the blockade of transcription and translation,
using Act. D and CHX, respectively. The treatment with both inhibitors
abolished expression of endogenous FL-PINK1 protein (Figs. 6B and C).
Also, we investigated if degradation mechanisms, such as UPS
andautophagy, modiﬁed PINK1 protein levels using MG-132 and Baf.
A1, respectively. In this sense, there was an accumulation of ΔN-
PINK1, but not FL-PINK1, in untreated and vehicle-treated cells after
the treatment of MG-132, as previously reported (Lin and Kang, 2008;
Takatori et al., 2008). Following CCCP treatment, ΔN-PINK1 levels
were decreased, which was expected as FL-PINK1 accumulates on the
outer mitochondrial membrane, thus reducing the amount of PINK1
available for cleavage by proteases in the inner mitochondrial mem-
brane. In contrast, the levels of FL-PINK1 were further increased when
we treated cells with CCCP and inhibited the autophagy mechanism
with Baf. A1 (blocking autophagosome/lysosome fusion) (Figs. 6D and
E). Western-blotting for COX IV and LC3-II protein levels indicatedthat Baf. A1 prevented the CCCP-induced decrease in mitochondrial
content (Figs. 6D and F) and inhibited autophagy ﬂux (Fig. S1). This sug-
gests that the further increase in FL-PINK1 levels after CCCP and Baf. A1
treatment was most likely due to a greater number of mitochondria on
which PINK1 could accumulate. Finally, FL-PINK1 protein was still in-
creased by CCCP in the presence of 17-AAG, an inhibitor of Hsp90
(Figs. 6D and E), further suggesting that the increase of FL-PINK1 at
24 h was due to de novo synthesis, rather than increased stabilization
of PINK1 (Lin and Kang, 2008).
Involvement of extracellular calcium in PINK1 levels
To examine whether the treatment with CCCP stimulated calcium
signaling and if this is associated with increased transcription of
PINK1, leading to the accumulation of FL-PINK1 on mitochondria, we
measured intracellular calcium mobilization in SH-SY5Y cells using
the ratiometric indicator Fura-2 AM. We found that the presence of
CCCP did not modify the release of calcium from an intracellular store
(Fig. 7A), but produced the entry of extracellular calcium and conse-
quently an elevation in cytosolic calcium levels immediately after treat-
ment (Fig. 7B). Next, we evaluated the mechanism of extracellular
calcium entry. We investigated whether calcium entry was dependent
on L- and N-type VDCCs, which are well characterized in SH-SY5Y
cells (Zhang et al., 2009) and have been implicated in PD pathogenesis
(Goldberg et al., 2012; Ilijic et al., 2011). We used 10 μM nifedipine
and 2 μM ω-CTX, and showed that the treatment with these VDCC
blockers signiﬁcantly reduced extracellular calcium entry (Figs. 7C and
D). Moreover, the blockade of intracellular calcium release from stores
such as ER (using thapsigargin), mitochondria (with rotenone) and ly-
sosomes (using Baf. A1) did not prevent the initial increase in intracel-
lular calcium observed after treatment with CCCP (data not shown).
Next, we analyzed the role of this intracellular calcium elevation
after the CCCP treatment on the PINK1 levels and its possible impor-
tance in the PINK1 mitochondrial localization. We observed that calci-
um chelation with BAPTA-AM decreased FL-PINK1 levels after CCCP
treatment, both in cell lysates (Figs. 7E and F) and isolatedmitochondria
(Figs. 7G and H). Chelation of calcium by BAPTA-AM was conﬁrmed by
ﬂow cytometry (Fig. S2). Furthermore, to assess whether cytosolic calci-
um increase could mimic the CCCP effects on PINK1 protein, cells were
exposed to the calcium ionophore ionomycin and the L-type VDCC ago-
nist Bay K 8644, showing that both did not modify FL-PINK1 protein
levels, comparable to vehicle-treated cells (Fig. S3).
PINK1 calcium-dependent gene expression
To elucidate if extracellular calcium increases the PINK1 mitochon-
drial localization by enhancing its gene expression, PINK1 mRNA levels
were measured by qPCR. PINK1 mRNA levels were signiﬁcantly de-
creased after 6 h of CCCP treatment when cytosolic calcium was elimi-
nated by BAPTA-AM (0.69 ± 0.09 times less than 6 hour CCCP-treated
cells) or extracellular calcium in the medium was chelated by EGTA
(0.77 ± 0.10 times less than 6 hour CCCP-treated cells) (Fig. 8A). But,
if the exposure is longer (24 h), these rates did not modulate when
we sequestered cytosolic (0.18 ± 0.25 times less than CCCP-treated
cells) and extracellular calcium (0.09 ± 0.62 times less than CCCP-
treated cells) (Fig. 8B). However, it would appear that decreased tran-
scription of PINK1 mRNA by BAPTA-AM or EGTA for at least 6 h was
sufﬁcient to decrease FL-PINK1 protein levels after 24 h of CCCP treat-
ment (Figs. 7E–H, 8C and D).
Nuclear recruitment and activation of c-Fos after the CCCP treatment
To further evaluate the role of calcium in PINK1 expression, we per-
formed some experiments to elucidate whether this higher gene ex-
pression under CCCP treatment is modulated by a transcription factor,
following activation by calcium. Bioinformatic analysis of the PINK1
Fig. 9.Nuclear recruitment of c-Fos after the CCCP treatment. (A and B) SH-SY5Y cells were exposedwith 10 μMCCCP, with vehicle (0.05% (v/v) ethanol) or without any treatment (con-
trol), harvested by trypsinization at different times and lysed. The protein levels of p-c-Fos (Ser32) and c-Fos were determined byWestern-blotting. α-tubulin expression was used as a
loading control. (A) Representative blot of at least three independent experiments. (B) Densitometry of each band expressed in arbitrary units of intensity (#p N 0.05; *p ≤ 0.05;
**p ≤ 0.01). (C–F) SH-SY5Y cells were exposed 3 h with 10 μM CCCP or with vehicle (0.05% (v/v) ethanol), ﬁxed and immunostained for p-c-Fos (Ser32) or c-Fos (green) and Ho
(blue). (C) Representative immunoﬂuorescence microphotographs. The arrows highlight high nuclear intensity of p-c-Fos (Ser32). (D) Representative immunoﬂuorescencemicrophoto-
graphs. The arrows highlight c-Fos nuclear staining. (E) Nuclear ﬂuorescence intensity per cell (in AU), stainingwith anti-p-c-Fos (Ser32) antibody (***p ≤ 0.001). (F) Percentages of cells
with nuclear c-Fos (***p ≤ 0.001). Scale bar represents 10 μm. Data were expressed as mean ± SEM; n = 200. (G and H) SH-SY5Y cells were exposed 3 hwith 10 μMCCCP, with vehicle
(0.05% (v/v) ethanol) orwithout any treatment (control), nuclear isolated andWestern-blotting performed. Lamin A/Cwas used as a nuclear loading control. (G) Representative blot of at
least three independent experiments. (H) Densitometry of each band expressed in arbitrary units of intensity (***p ≤ 0.001). Molecular mass is indicated in kDa next to the blots. Data
were expressed as mean ± SEM; n = 3.
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served that CCCP treatment increased the phosphorylation of c-Fos at
residue Ser32 between 3 and 6 h, when compared with cells treated
with the vehicle (Figs. 9A and B). Immunoﬂuorescence of c-Fos
also showed that CCCP treatment produced higher levels of p-c-Fos
(Ser32) (7.06 ± 2.85 AU of nuclear ﬂuorescence intensity/cell), com-
pared to vehicle-treated cells (2.84 ± 1.27 AU) (Figs. 9C and E). The
nuclear localization of c-Fos was also increased by CCCP treatment
(58.22 ± 11.02% of CCCP-treated cells vs. 11.36 ± 5.80% of vehicle-
treated cells) (Figs. 9D and F). The nuclear translocation of c-Fos was
also conﬁrmed by Western-blotting (Figs. 9G and H). We analyzed
other factors modulated by calcium, such as CREB, c-Jun, FOXO3a and
NFκB, but obtained inconclusive results (data not shown).
c-Fos calcium-dependent signaling acts in parallel to PINK1 expression after
CCCP exposure
To elucidate if extracellular calcium enhanced PINK1 expression via
c-Fos activation, ﬁrstly, we analyzed the phosphorylation of c-Fos after
a combination of CCCP exposure and deprivation of cytosolic or extra-
cellular calcium. Both BAPTA-AM and EGTA treatment with CCCP de-
creased phosphorylation of c-Fos (Figs. 10A and B). Finally, we set out
to determine whether the c-Fos/PINK1 axis was in the same pathway.
Following c-fos gene silencing, PINK1 protein levels did not change(Figs. 10E and F) after the 24 h CCCP treatment, and vice versa, the si-
lencing of PINK1 did not affect the c-Fos phosphorylation, that appeared
when cells were exposed to uncoupler for 3 h (Figs. 10C and D). Further
studies are needed to elucidate which mechanisms control PINK1 gene
expression.
CCCP-induced mitophagy is calcium-dependent, but is a c-Fos independent
mechanism
At this point, we considered whether mitophagy could be modulat-
ed by calcium and/or c-Fos signaling. SH-SY5Y cells treated with CCCP
and BAPTA-AM or EGTA increased COX IV protein levels, when com-
pared to cells treated with CCCP alone. However, LC3 protein levels
were increased to a similar extent in cells treated with CCCP alone, or
in combination with BAPTA-AM or EGTA (Figs. 11A and B). Moreover,
if we analyzed LC3 and COX IV levels after the c-fos gene silencing, we
observed the same pattern as the Lipofectamine condition (Figs. 11C
and D), showing how this reagent generates an accumulation of LC3-II
protein levels (Mo et al., 2012).
Discussion
We report that depolarization of mitochondria with CCCP in SH-
SY5Y cells results in a calcium-dependent increase in transcription of
Fig. 10. c-Fos-independent expression of PINK1 after CCCP exposure. (A and B) SH-SY5Y cellswere preincubated 1 hwith 5 μMBAPTA-AMor 500 μMEGTA, exposed 3 hwith 10 μMCCCP,
harvested by trypsinization and lysed. The protein levels of p-c-Fos (Ser32)were determined byWestern-blotting.α-tubulin expressionwas used as a loading control. (A) Representative
blot of at least three independent experiments. (B) Densitometry of each band expressed in arbitrary units of intensity (***p ≤ 0.001). (C–F) SH-SY5Y cells were transfected with c-fos
siRNA, PINK1 siRNA or scrambled control siRNA for 2 days and treated with 10 μM CCCP, harvested by trypsinization at different times and lysed. The protein levels of p-c-Fos (Ser32),
c-Fos and PINK1 were determined by Western-blotting. α-tubulin expression was used as a loading control. (C) Representative blot of at least three independent experiments, from
3 hour-CCCP-treated cells. (D) Densitometry of each band expressed in arbitrary units of intensity (#p N 0.05; ***p ≤ 0.001). (E) Representative blot of at least three independent exper-
iments, from 24 hour-CCCP-treated cells. (F) Densitometry of each band expressed in arbitrary units of intensity (#p N 0.05; ***p ≤ 0.001). Molecularmass is indicated in kDa next to the
blots. Data were expressed as mean ± SEM; n = 3.
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chondrialmembrane. Previously, it has been shown that FL-PINK1 accu-
mulates on the outer mitochondrial membrane of mitochondria within
15 min (Matsuda et al., 2010; D.P. Narendra et al., 2010; Shiba-
Fukushima et al., 2012). Similar to these previous reports, we also
found that the accumulation of FL-PINK1 was diminished after 15 min
of CCCP being removed, presumably because upon restoration of the
mitochondrial membrane potential, FL-PINK1 was able to proceed to
the inner mitochondrial membrane to be processed by mitochondrial
proteases (Deas et al., 2011; Greene et al., 2012; Jin et al., 2010) and
then be degraded by the proteasome (Jin et al., 2010; Lin and Kang,
2008; Takatori et al., 2008).
These reports have typically looked at FL-PINK1 protein levels up to
6 h after CCCP treatment. However, we are not aware of any reports of
PINK1 mRNA levels following CCCP treatment. We found that PINK1
mRNA levels were signiﬁcantly increased after 6 h of CCCP treatment
and continued to rise for 24 h. This resulted in a continued increase in
de novo FL-PINK1 protein, which accumulated on mitochondria. The
increase in FL-PINK1 protein at the mitochondria after 24 h occurred
despite a 29% decrease in mitochondrial content. This highlights the
importance of PINK1 on damaged mitochondria. It should be noted
that we found that washing away of CCCP after 6 h, and measuring
mitochondrial content 18 h later (24 h in total), no longer resulted in
a signiﬁcant decrease in mitochondria content. This is despite the fact
that the recruitment of Parkin to mitochondria by PINK1 (Matsuda
et al., 2010; D.P. Narendra et al., 2010; Vives-Bauza et al., 2010), and
the PINK1/Parkin-dependent ubiquitination of mitochondrial proteins
such as VDAC and the mitofusins, and the mitochondrial transport pro-
tein Miro, occurred within 3 h of mitophagy induction (Chan et al.,
2011; Gegg et al., 2010; Geisler et al., 2010; Tanaka et al., 2010). Our re-
sults suggest that maximum activity of mitophagy (as measured bycolocalization of LC3withmitochondria) occurred at 12 h of CCCP treat-
ment, meanwhile mitochondrial PINK1 localization continued increas-
ing for at least 24 h. This suggests that FL-PINK1 might have further
functions in mitochondrial quality control downstream of the recruit-
ment of Parkin and ubiquitination of mitochondrial proteins.
Higher PINK1 expression could be linked with a compensatory in-
crease in mitochondrial biogenesis. The induction of mitophagy would
require the cell to initiate synthesis of new mitochondria to replace
them. PINK1 has been linked with mitochondrial biogenesis, with
knockdown of PINK1 in SH-SY5Y cells decreasing mtDNA levels and
mtDNA synthesis (Gegg et al., 2009). Induction of mitochondrial
uncoupling proteins can induce mitochondrial biogenesis via the tran-
scription factor Nrf1 (Li et al., 1999). Therefore it is unclear whether
any putative increase inmitochondrial biogenesis following CCCP treat-
ment is a direct response tomitochondrial uncoupling or the removal of
mitochondria.
This increase in transcription appeared to be due to an increase in
intracellular calcium levels. Treatment of SH-SY5Y cells with CCCP
increased calcium levels within the cell, with uptake of calcium into
cells via the L- and N-type VDCCs as a major component. In this sense,
higher levels of intracellular calcium after FCCP (CCCP analog) exposure
are reduced in calcium-free solution or by VDCC blockade (Buckler
and Vaughan-Jones, 1998; Sato, 1997). More sensitive techniques are
required to determine if small local increases in cytosolic calcium
could also be caused as a result of increased mitochondrial release
upon depolarization (Tonkikh and Carlen, 2009). The increase in
PINK1 expression did not occur when intracellular calcium was in-
creased by ionomycin or an L-VDCC agonist. Ionomycin treatment has
previously been shown not to result in the phosphorylation of Ser65 of
Parkin by PINK1, an early event in mitophagy (Kondapalli et al., 2012).
We suspect that we did not see the increase in PINK1 transcription
Fig. 11.Mitophagy decreases after calcium chelation, but is a c-Fos-independent mecha-
nism. (A and B) SH-SY5Y cells were preincubated 1 h with 5 μM BAPTA-AM or 500 μM
EGTA, exposed 24 h with 10 μM CCCP, harvested by trypsinization and lysed. The ratio
LC3-II/LC3-I and protein levels of COX IV were determined by Western-blotting. α-
tubulin expression was used as a loading control. (A) Representative blot of at least
three independent experiments. (B) Densitometry of each band expressed in arbitrary
units of intensity (#p N 0.05; **p ≤ 0.01). (C and D) SH-SY5Y cells were transfected
with c-fos siRNA, PINK1 siRNA or scrambled control siRNA for 2 days and treated 24 h
with 10 μMCCCP, harvested by trypsinization and lysed. The ratio LC3-II/LC3-I and protein
levels of COX IVwere determined byWestern-blotting.α-tubulin expression was used as
a loading control. (C) Representative blot of at least three independent experiments.
(D) Densitometry of each band expressed in arbitrary units of intensity (#p N 0.05).
Molecular mass is indicated in kDa next to the blots. Data were expressed as mean ±
SEM; n = 3.
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andwere thus still able to buffer the calcium overload generated by ion-
ophores or the L-VDCC agonist. While treatment with calcium chelators
prevented loss of mitochondrial content following 24 h of CCCP treat-
ment, further work is required to determine whether this is directly
due to the decrease in PINK1 transcription, or other effects of decreased
calcium on other components of the autophagy machinery.
Therefore, the induction of PINK1 expression might simply be a pro-
tective measure against the increased cytosolic calcium observed after
CCCP treatment. Indeed, there was an increase in nuclear condensation
and PI-positive cells following 24 h of CCCP treatment. PINK1 expres-
sion is known to protect against a variety of stressors including
staurosporine, MPTP and oxidative stress (Gegg et al., 2009; Haque
et al., 2008;Wood-Kaczmar et al., 2008). Deregulation of mitochondrial
calcium homeostasis is also associated with loss of PINK1 function
(Abramov et al., 2011; Akundi et al., 2011; Gandhi et al., 2009;
Heeman et al., 2011), suggesting that increased mitochondriallocalization of PINK1 could lead to maintain functional interactions, ac-
tivating channels and transporters along the mitochondrial network
such asmPTP and NCXmito, to regulate calcium homeostasis and for in-
stance, minimize potential excitotoxic effects. Very recently, a report
has shown that PINK1 could prevent mitochondrial calcium overload
through the activation of isoforms NCX2 and NCX3 (Wood-Kaczmar
et al., 2013). Related to this, the Parkin mitochondrial localization
enhances ER-mitochondria crosstalk, favoring the calcium transfer
(Cali et al., 2013). Moreover, our results suggest that calcium overload
could be necessary for the mitochondrial removal by PINK1/Parkin-
mediated mitophagy (Narendra et al., 2008; D.P. Narendra et al., 2010).
The identity of the transcription factor responsible for the increased
PINK1 transcription is unknown. FOXO3a increased PINK1 transcription
in T-lymphocytes, MCF7 and SH-SY5Y cells upon growth factor/serum
deprivation (Mei et al., 2009). PINK1 transcription was also no longer
increased following ischemia in FOXO1 and FOXO3 knock-out mice
(Sengupta et al., 2011). However there was no evidence of FOXO3a in-
creasing PINK1 transcription following treatment with CCCP. In this re-
port, while we found that c-Fos translocated to the nucleus upon CCCP
exposure, this had no effect on PINK1 protein levels. It is well-known
that c-Fos is activated after pathological situations, such as hypoxia or
ischemia (Cho et al., 2001), mediated by L- and N-type VDCCs
(Premkumar et al., 2000; Zhao et al., 2007), so related to our results, c-
Fos might be involved in adaptative responses upon calcium overload
and mitochondrial depolarization promoting neuronal survival.
Conclusions
This study shows that treatment of SH-SY5Y cells with CCCP in-
creases PINK1 gene expression for at least 24 h, leading to a large ac-
cumulation of PINK1 protein on damaged mitochondria. This
increase was calcium-dependent and might be via an inﬂux of calcium
via L- and N-type VDCCs, allowing for the mitochondrial removal by
mitophagy. Moreover, the transcription factor c-Fos was activated by
calcium, althoughwas not responsible for induction of PINK1 transcrip-
tion. The induction of PINK1 expression and activation of c-Fos could be
a mechanism by which the cell activates neuroprotective mechanisms
that might result in restoring calcium homeostasis and/or promote mi-
tochondrial biogenesis (Fig. 12).
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